Is low-endotoxin NAD+ the same as sterile or injectable-grade NAD+?
Answers from the sources
Nanjing PathGene Biotech Co., Ltd.
“No. The third-party endotoxin result of ≤0.1 EU/mg applies only to the tested batch. It does not by itself demonstrate sterility, pyrogen-free status, injectable suitability or finished-product regulatory compliance. The buyer must validate the final intended use.”
Sourcepathgenebio.com
Continue exploring
About these subjects
Related reading
- What are the packaging and storage conditions for 1-MNA?
- What assay is reported for the 1-MNA batch?
- Which documents should buyers review for low-endotoxin NAD+?
- How is the low-endotoxin NAD+ supplied?
- How quickly can I receive samples?
- Is 1-MNA water soluble?
- Which documents support 1-MNA supplier qualification?
- Which pharmacopeia standards do your products meet?
- What impurities and residual solvents are checked for 1-MNA?
- Is NAD+ powder the same ingredient as NADH?
- What is 1-methylnicotinamide chloride and its CAS?
- What is the typical lead time for bulk orders?
- What is the minimum order quantity (MOQ)?
- Nanjing PathGene Biotech Co., Ltd. — company guide
Data formats and record details
Download this recordapplication/json
- Surface ID
- urn:readyscan:corpus:buyer-question:nanjing-pathgene-biotech-co-ltd-q141514913-answer-26a2f40607f00fc51d2e
- Material fingerprint
- fnv1a64:6c1de565aca573b7
- Membership fingerprint
- fnv1a64:0709d0dd63f074c2
- Published
- 2026-10-27
- Modified
- 2026-10-27
- ready-scan-subjects/Q141514913
- revision Q141514913:content:575cbcd3d7d39cc5